Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Castelli

Showing results (411-420 of 425) with videos related to

Pageof 43
Sort By:
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
International Journal of Epidemiology|October 9, 2015
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort)Carlo Torti, Elena Raffetti, Francesco Donato, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 5, 2015
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus ConferenceGian Luca Baiocchi, Domenico D'Ugo, Daniel Coit, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
Cytokine|December 18, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumoniaCharilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
JCI Insight|November 24, 2020
An immune-based biomarker signature is associated with mortality in COVID-19 patientsMichael S Abers, Ottavia M Delmonte, Emily E Ricotta, et al.
Autoimmunity Reviews|May 8, 2020
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, ItalyPaola Toniati, Simone Piva, Marco Cattalini, et al.
Pageof 43

Showing results (411-420 of 425) with videos related to

Sort By:
Pageof 43
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
International Journal of Epidemiology|October 9, 2015
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort)Carlo Torti, Elena Raffetti, Francesco Donato, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 5, 2015
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus ConferenceGian Luca Baiocchi, Domenico D'Ugo, Daniel Coit, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
Cytokine|December 18, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumoniaCharilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
JCI Insight|November 24, 2020
An immune-based biomarker signature is associated with mortality in COVID-19 patientsMichael S Abers, Ottavia M Delmonte, Emily E Ricotta, et al.
Autoimmunity Reviews|May 8, 2020
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, ItalyPaola Toniati, Simone Piva, Marco Cattalini, et al.
Pageof 43